Amplex Red Workflows for H2O2 and Enzyme Assays
2026-08-13
Amplex Red converts hydrogen peroxide formation into a sensitive fluorescent readout for redox biology, peroxidase studies, and enzyme-inhibitor screening. This guide adapts the standardized autotaxin workflow into practical assay setup, kinetic validation, false-positive control, and troubleshooting strategies.
HyperScript First-Strand cDNA Synthesis Kit for Stress RNA
2026-08-13
Translate plant stress transcriptomics into sensitive, reproducible PCR amplification and qPCR reaction workflows. The HyperScript First-Strand cDNA Synthesis Kit combines high-temperature reverse transcription, flexible primer selection, and strong performance with low-abundance or structurally difficult RNA templates.
Carboxylesterase Confounds Mitochondrial H2O2 Assays
2026-08-12
Miwa and colleagues showed that carboxylesterases can convert Amplex Red to fluorescent resorufin without hydrogen peroxide, horseradish peroxidase, or oxygen. This finding identifies a major matrix-dependent confounder in mitochondrial H2O2 release assays and supports the use of enzyme controls, inhibitor controls, and orthogonal measurements.
BMS-777607 for MET and Platelet Research
2026-08-12
BMS-777607 is an ATP-competitive c-Met inhibitor for dissecting MET-family signaling in cancer metastasis models and exploratory hiPSC-derived megakaryocyte workflows. This guide connects validated kinase inhibition data with practical compound handling, assay design, troubleshooting, and platelet-production optimization.
Ivermectin: Mechanism and Research Workflow
2026-08-11
Ivermectin is a broad-spectrum anti-parasitic drug with a defined neuromuscular mechanism and established human indications. This guide connects product specifications, parasitology research applications, assay controls, and evidence boundaries without extending parasite data into unsupported cancer or antiviral claims.
Rocilinostat (ACY-1215) for HDAC6 Research
2026-08-10
Rocilinostat, also called ACY-1215, is a selective HDAC6 inhibitor with a reported biochemical IC50 of 5 nM. Preclinical multiple myeloma models associate HDAC6 inhibition with reduced viability, increased apoptosis, and enhanced activity with proteasome inhibitors, while product-specific handling requires DMSO formulation and storage at −20°C.
Regorafenib Workflows for Cancer Research
2026-08-09
Regorafenib (BAY 73-4506) combines multikinase pathway coverage with practical applications in angiogenesis, melanoma, migration, and tumor xenograft models. This workflow-oriented guide connects dose selection and assay controls with the RRM2–ERK/E2F3 mechanism reported in melanoma research.
4-Hydroxytamoxifen: Protocol and QC Guide
2026-08-08
This dossier-led guide explains how to configure DMSO-based workflows with 4-Hydroxytamoxifen (SKU B6167) for estrogen receptor modulation, cancer studies, apoptosis assays, and cardiac myocyte experiments. It is unsuitable for protocols requiring water or ethanol solubility, and published assay-specific parameters should not be inferred when directly matched paper evidence is unavailable.
Ibotenic Acid: NMDA Receptor Agonist Workflows
2026-08-07
Ibotenic acid is an NMDA receptor agonist and practical neuroscience research tool for linking glutamatergic signaling modulation to behavior, biochemical changes, and neuronal injury. This workflow emphasizes fresh solution preparation, dose–time matching, and complementary c-fos and Nissl readouts for more interpretable neurodegenerative disease models.
ALDH1A3-miR-7-TGFBR2 Axis Regulates CD44 in Breast Cancer St
2026-08-07
This study uncovers a regulatory axis involving ALDH1A3, miR-7, TGFBR2, Smad3, and CD44 in breast cancer stem cells, clarifying how ALDH1A3 knockdown suppresses CD44 expression through microRNA and TGF-β pathway modulation. The findings illuminate new mechanistic strategies for targeting aggressive breast cancer cell subsets.
T-5224: C-Fos/AP-1 Inhibitor for Arthritis and Myeloma Resea
2026-08-06
T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, empowers researchers to precisely dissect and modulate inflammatory and osteoclastogenic pathways in both arthritis and multiple myeloma models. This guide details optimized workflows, protocol parameters, and troubleshooting insights—bridged by the latest evidence on PI3K/AKT-driven ferroptosis—to help scientists unlock the full translational impact of T-5224.
SARS-CoV-2 N Protein Suppresses GADD34-Mediated Immunity via
2026-08-06
This study reveals how the SARS-CoV-2 nucleocapsid protein impairs the host innate immune response by antagonizing GADD34 function through the formation of atypical stress granule foci. These findings highlight a novel viral strategy to evade interferon signaling and suggest new therapeutic targets for antiviral intervention.
Y-27632 Dihydrochloride: ROCK Inhibitor Workflows & Optimiza
2026-08-05
Y-27632 dihydrochloride, a potent ROCK inhibitor, enables consistent stem cell viability, modulates stress fiber formation, and suppresses tumor invasion in diverse research settings. This guide delivers actionable protocols, troubleshooting advice, and practical translation of recent advances in interspecies chimerism to help researchers unlock the full potential of Y-27632 in cytoskeletal and cancer biology.
Triamcinolone (B1859): Technical Use for Glucocorticoid Rese
2026-08-05
Triamcinolone is a synthetic glucocorticoid agonist designed for research applications involving glucocorticoid signaling, anti-inflammatory studies, and immunosuppression assays. It addresses the need for controlled, reproducible modulation of glucocorticoid receptor pathways in vitro. This product is not suitable for diagnostic or clinical use.
PD 0332991 (Palbociclib) HCl: Apoptotic Signaling Beyond CDK
2026-08-04
Explore how PD 0332991 (Palbociclib) HCl enables not just cell cycle arrest but also reveals advanced apoptotic signaling mechanisms in cancer research. This in-depth analysis integrates the latest mechanistic insights to guide innovative assay design.
479 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page